[144] Rocket Pharmaceuticals, Inc. SEC Filing
Form 144 notice for Rocket Pharmaceuticals, Inc. (RCKT): The filing notifies a proposed sale of 699 common shares through Fidelity Brokerage Services LLC on 08/18/2025, with an aggregate market value of $2,142.57. The shares were acquired by the seller via restricted stock vesting on 08/14/2025 and were issued as compensation. The filing also reports sales by the same person earlier this year: 357 shares sold on 05/20/2025 for $2,301.22 and 7,043 shares sold on 08/14/2025 for $21,260.70. The issuers outstanding shares are listed as 107,903,871.
Avviso Modulo 144 per Rocket Pharmaceuticals, Inc. (RCKT): Il deposito notifica una proposta di vendita di 699 azioni ordinarie tramite Fidelity Brokerage Services LLC in data 18/08/2025, con un valore di mercato complessivo di $2.142,57. Le azioni sono state acquisite dal venditore tramite vesting di azioni soggette a restrizioni il 14/08/2025 e sono state emesse come compenso. Il deposito segnala inoltre vendite della stessa persona avvenute in precedenza quest'anno: 357 azioni vendute il 20/05/2025 per $2.301,22 e 7.043 azioni vendute il 14/08/2025 per $21.260,70. Le azioni in circolazione dell'emittente sono indicate come 107.903.871.
Aviso Formulario 144 para Rocket Pharmaceuticals, Inc. (RCKT): La presentaci贸n notifica una propuesta de venta de 699 acciones ordinarias a trav茅s de Fidelity Brokerage Services LLC el 18/08/2025, con un valor de mercado agregado de $2.142,57. Las acciones fueron adquiridas por el vendedor mediante vesting de acciones restringidas el 14/08/2025 y se emitieron como 肠辞尘辫别苍蝉补肠颈贸苍. La presentaci贸n tambi茅n informa ventas de la misma persona ocurridas anteriormente este a帽o: 357 acciones vendidas el 20/05/2025 por $2.301,22 y 7.043 acciones vendidas el 14/08/2025 por $21.260,70. Las acciones en circulaci贸n del emisor se registran como 107.903.871.
Rocket Pharmaceuticals, Inc. (RCKT)鞐� 雽�頃� Form 144 韱奠: 氤� 鞝滌稖 靹滊電� 2025-08-18鞐� Fidelity Brokerage Services LLC毳� 韱淀暣 699 氤错喌欤茧ゼ 毵り皝頃� 鞓堨爼鞛勳潉 韱奠頃橂┌, 齑� 鞁滉皜 臧�旃橂姅 $2,142.57鞛呺媹雼�. 頃措嫻 欤检嫕鞚� 韺愲Г鞛愱皜 2025-08-14鞐� 鞝滍暅攵� 欤检嫕(Restricted Stock) 氩犾姢韺�鞙茧 旆摑頄堨溂氅� 氤挫儊鞙茧 氚滍枆霅橃棃鞀惦媹雼�. 霃欖澕鞚胳澊 鞓暣 齑堨棎 鞁れ嫓頃� 毵り皝霃� 氤搓碃霅橃柎 鞛堨姷雼堧嫟: 2025-05-20鞐� 357欤茧ゼ $2,301.22鞐� 毵り皝, 攴鸽Μ瓿� 2025-08-14鞐� 7,043欤茧ゼ $21,260.70鞐� 毵り皝頄堨姷雼堧嫟. 氚滍枆靷潣 鞙犿喌 欤检嫕靾橂姅 107,903,871搿� 旮办灛霅橃柎 鞛堨姷雼堧嫟.
Avis Formulaire 144 pour Rocket Pharmaceuticals, Inc. (RCKT) : le d茅p么t notifie une proposition de vente de 699 actions ordinaires via Fidelity Brokerage Services LLC le 18/08/2025, pour une valeur de march茅 totale de 2 142,57 $. Les actions ont 茅t茅 acquises par le vendeur lors du vesting d'actions restreintes le 14/08/2025 et ont 茅t茅 茅mises 脿 titre de 谤茅尘耻苍茅谤补迟颈辞苍. Le d茅p么t signale 茅galement des ventes par la m锚me personne plus t么t cette ann茅e : 357 actions vendues le 20/05/2025 pour 2 301,22 $ et 7 043 actions vendues le 14/08/2025 pour 21 260,70 $. Les actions en circulation de l'茅metteur sont indiqu茅es comme 107 903 871.
Form 144-Mitteilung 蹿眉谤 Rocket Pharmaceuticals, Inc. (RCKT): Die Einreichung k眉ndigt den geplanten Verkauf von 699 Stammaktien 眉ber Fidelity Brokerage Services LLC am 18.08.2025 an, mit einem aggregierten Marktwert von $2.142,57. Die Aktien wurden vom Verk盲ufer durch Restricted-Stock-Vesting am 14.08.2025 erworben und als 痴别谤驳眉迟耻苍驳 ausgegeben. Die Meldung berichtet au脽erdem 眉ber fr眉here Verk盲ufe derselben Person in diesem Jahr: 357 Aktien verkauft am 20.05.2025 蹿眉谤 $2.301,22 und 7.043 Aktien verkauft am 14.08.2025 蹿眉谤 $21.260,70. Die ausstehenden Aktien des Emittenten werden mit 107.903.871 angegeben.
- None.
- None.
Insights
TL;DR: Routine insider sale following restricted stock vesting; amounts disclosed are small in absolute dollar terms.
The Form 144 documents a proposed sale of 699 common shares acquired via restricted stock vesting on 08/14/2025 and intended to be sold on 08/18/2025 through Fidelity. Two prior sales by the same person earlier in 2025 are disclosed, totaling 7,400 shares. The filing meets Rule 144 disclosure requirements by identifying acquisition dates, nature of acquisition (compensation), broker, and proceeds. From a trading-impact perspective, these transactions appear routine and procedural rather than materially transformative for the issuer.
TL;DR: Disclosure is complete for the transactions shown; this appears to be standard compliance with insider sale rules.
The filer indicates the securities were issued as compensation and vested on 08/14/2025, with planned sale on 08/18/2025. The notice includes prior sales in the past three months, consistent with aggregation requirements. The signer attests they possess no undisclosed material adverse information. This filing documents compliance with Rule 144 and provides transparent traceability of insider dispositions.
Avviso Modulo 144 per Rocket Pharmaceuticals, Inc. (RCKT): Il deposito notifica una proposta di vendita di 699 azioni ordinarie tramite Fidelity Brokerage Services LLC in data 18/08/2025, con un valore di mercato complessivo di $2.142,57. Le azioni sono state acquisite dal venditore tramite vesting di azioni soggette a restrizioni il 14/08/2025 e sono state emesse come compenso. Il deposito segnala inoltre vendite della stessa persona avvenute in precedenza quest'anno: 357 azioni vendute il 20/05/2025 per $2.301,22 e 7.043 azioni vendute il 14/08/2025 per $21.260,70. Le azioni in circolazione dell'emittente sono indicate come 107.903.871.
Aviso Formulario 144 para Rocket Pharmaceuticals, Inc. (RCKT): La presentaci贸n notifica una propuesta de venta de 699 acciones ordinarias a trav茅s de Fidelity Brokerage Services LLC el 18/08/2025, con un valor de mercado agregado de $2.142,57. Las acciones fueron adquiridas por el vendedor mediante vesting de acciones restringidas el 14/08/2025 y se emitieron como 肠辞尘辫别苍蝉补肠颈贸苍. La presentaci贸n tambi茅n informa ventas de la misma persona ocurridas anteriormente este a帽o: 357 acciones vendidas el 20/05/2025 por $2.301,22 y 7.043 acciones vendidas el 14/08/2025 por $21.260,70. Las acciones en circulaci贸n del emisor se registran como 107.903.871.
Rocket Pharmaceuticals, Inc. (RCKT)鞐� 雽�頃� Form 144 韱奠: 氤� 鞝滌稖 靹滊電� 2025-08-18鞐� Fidelity Brokerage Services LLC毳� 韱淀暣 699 氤错喌欤茧ゼ 毵り皝頃� 鞓堨爼鞛勳潉 韱奠頃橂┌, 齑� 鞁滉皜 臧�旃橂姅 $2,142.57鞛呺媹雼�. 頃措嫻 欤检嫕鞚� 韺愲Г鞛愱皜 2025-08-14鞐� 鞝滍暅攵� 欤检嫕(Restricted Stock) 氩犾姢韺�鞙茧 旆摑頄堨溂氅� 氤挫儊鞙茧 氚滍枆霅橃棃鞀惦媹雼�. 霃欖澕鞚胳澊 鞓暣 齑堨棎 鞁れ嫓頃� 毵り皝霃� 氤搓碃霅橃柎 鞛堨姷雼堧嫟: 2025-05-20鞐� 357欤茧ゼ $2,301.22鞐� 毵り皝, 攴鸽Μ瓿� 2025-08-14鞐� 7,043欤茧ゼ $21,260.70鞐� 毵り皝頄堨姷雼堧嫟. 氚滍枆靷潣 鞙犿喌 欤检嫕靾橂姅 107,903,871搿� 旮办灛霅橃柎 鞛堨姷雼堧嫟.
Avis Formulaire 144 pour Rocket Pharmaceuticals, Inc. (RCKT) : le d茅p么t notifie une proposition de vente de 699 actions ordinaires via Fidelity Brokerage Services LLC le 18/08/2025, pour une valeur de march茅 totale de 2 142,57 $. Les actions ont 茅t茅 acquises par le vendeur lors du vesting d'actions restreintes le 14/08/2025 et ont 茅t茅 茅mises 脿 titre de 谤茅尘耻苍茅谤补迟颈辞苍. Le d茅p么t signale 茅galement des ventes par la m锚me personne plus t么t cette ann茅e : 357 actions vendues le 20/05/2025 pour 2 301,22 $ et 7 043 actions vendues le 14/08/2025 pour 21 260,70 $. Les actions en circulation de l'茅metteur sont indiqu茅es comme 107 903 871.
Form 144-Mitteilung 蹿眉谤 Rocket Pharmaceuticals, Inc. (RCKT): Die Einreichung k眉ndigt den geplanten Verkauf von 699 Stammaktien 眉ber Fidelity Brokerage Services LLC am 18.08.2025 an, mit einem aggregierten Marktwert von $2.142,57. Die Aktien wurden vom Verk盲ufer durch Restricted-Stock-Vesting am 14.08.2025 erworben und als 痴别谤驳眉迟耻苍驳 ausgegeben. Die Meldung berichtet au脽erdem 眉ber fr眉here Verk盲ufe derselben Person in diesem Jahr: 357 Aktien verkauft am 20.05.2025 蹿眉谤 $2.301,22 und 7.043 Aktien verkauft am 14.08.2025 蹿眉谤 $21.260,70. Die ausstehenden Aktien des Emittenten werden mit 107.903.871 angegeben.
FAQ
What does the Form 144 for RCKT disclose about the planned sale?
How were the 699 shares acquired according to the filing?
Who is the seller named in the Form 144 and what prior sales are reported?
What outstanding share count does the filing show for the issuer?
Does the filing state whether the seller knows any undisclosed material information?
